Bayer to Invest 2.2 Billion U.S. Dollars In A New Manufacturing Site in the United States
06 October 2026, Ohio: Bayer announced on Friday plans to invest 2.2 billion U.S. dollars in a new pharmaceutical manufacturing site in
Read MoreFind the latest news, research, product launches, financial results, investments, partnerships, regulatory developments, and business updates from Bayer. Stay informed on Crop Science, pharmaceuticals, consumer health, crop protection, seeds, biologicals, digital agriculture, healthcare, sustainability, and global business developments.
Bayer AG is a global life science company headquartered in Leverkusen, Germany, operating through three divisions: Crop Science, Pharmaceuticals, and Consumer Health. Its businesses develop products and technologies across agriculture and healthcare, with the company focused on addressing challenges related to food security, climate change, disease prevention, and healthcare access. Bayer’s global portfolio includes seeds, biotechnology traits, crop protection products, digital agriculture solutions, prescription medicines, and consumer healthcare brands.
The Crop Science division is particularly relevant to agriculture, with activities spanning seeds and traits, herbicides, fungicides, insecticides, biologicals, digital farming, and agricultural research. Bayer is advancing a pipeline of new agricultural products while focusing on technologies designed to improve farm productivity, resource efficiency, and resilience. Its current agricultural strategy includes a portfolio of ten planned blockbuster launches.
In India, Bayer has been present for more than 130 years and operates through businesses including Crop Science, Pharmaceuticals and Consumer Health. Bayer CropScience Limited is the group’s listed Indian Crop Science company, with activities covering crop protection, seeds, traits, biologicals and digital farming. The India Crop Science business works with more than 30 million smallholder farmers and focuses on crops including rice, corn, cotton, fruits and vegetables.
Bayer’s global developments in 2026 include Crop Science innovation, financial performance, product pipeline advancement, agricultural technology, sustainability, glyphosate litigation, and strategic investments. The company reported higher Crop Science sales and substantial earnings growth in both the first and second quarters of 2026.
This category features Bayer news, Crop Science, Bayer CropScience India, crop protection, seeds, herbicides, fungicides, insecticides, biologicals, digital agriculture, product launches, R&D, financial results, regulatory developments, sustainability, glyphosate, leadership, investments, partnerships, and global agriculture and healthcare developments.
06 October 2026, Ohio: Bayer announced on Friday plans to invest 2.2 billion U.S. dollars in a new pharmaceutical manufacturing site in
Read More21 September 2026, Cambridge: Robigo, a biotechnology company engineering no-compromise biological solutions for crop protection, today announced a Series A funding led
Read More14 September 2026, Washington, D.C: Newly released government records show that the US Environmental Protection Agency let Bayer choose among competing drift
Read More04 September 2026, Iowa: Bayer has begun commercialising products under its plan to bring 10 blockbusters to market over 10 years, with
Read More03 September 2026, Iowa: Bayer is implementing its previously announced ambition to bring 10 blockbusters to market over 10 years, beginning to launch major
Read More08 August 2026, Leverkusen: The Bayer Group continued to make headway in the second quarter of 2026, capping off a successful
Read More07 August 2026, Mumbai: Bayer CropScience Limited (BSE: 506285) announced today its unaudited results for the first quarter (Q1) of Financial Year
Read More04 August 2026, Leverkusen: Bayer reported stronger second-quarter performance in 2026, with its Crop Science division emerging as the company’s best-performing business,
Read More15 July 2026, Ames: Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by
Read More15 July 2026, Monheim: Bayer enters an exclusive licensing agreement with RAGT, a leading company in the European wheat seed market, advancing
Read More